Aarti Pharmalabs Ltd vs Desh Rakshak Aushdhalaya Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 14, 2026

Key Highlights

The Latest Trading Price of Aarti Pharmalabs Ltd is ₹ 641.25 as of 12 Jun 15:30 . The P/E Ratio of Aarti Pharmalabs Ltd changed from 12.9 on March 2023 to 24.9 on March 2025 . This represents a CAGR of 24.51% over 3 yearsThe P/E Ratio of Desh Rakshak Aushdhalaya Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Aarti Pharmalabs Ltd changed from ₹ 2489 crore on March 2023 to ₹ 6784 crore on March 2025 . This represents a CAGR of 39.69% over 3 yearsThe Market Cap of Desh Rakshak Aushdhalaya Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Aarti Pharmalabs Ltd for the Mar '26 is ₹ 596.21 crore as compare to the Dec '25 revenue of ₹ 436.83 crore. This represent the growth of 36.49% The revenue of Desh Rakshak Aushdhalaya Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Aarti Pharmalabs Ltd for the Mar '26 is ₹ 126.7 crore as compare to the Dec '25 ebitda of ₹ 104.07 crore. This represent the growth of 21.74% The ebitda of Desh Rakshak Aushdhalaya Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Aarti Pharmalabs Ltd changed from ₹ 55.45 crore to ₹ 61.12 crore over 8 quarters. This represents a CAGR of 4.99% The net profit of Desh Rakshak Aushdhalaya Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The Dividend Payout of Aarti Pharmalabs Ltd changed from 10.55 % on March 2023 to 17.61 % on March 2025 . This represents a CAGR of 18.62% over 3 yearsThe Dividend Payout of Desh Rakshak Aushdhalaya Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Aarti Pharmalabs Ltd

Aarti Pharmalabs Limited was initially incorporated as 'Aarti Organics Limited' in 2019.
The name of the Company was changed to Aarti Pharmachem Limited from Aarti Organics Limited' in July, 2021 and to Aarti Pharmalabs Limited in 2022.
Company is a manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, New Chemical Entities (NCE), and Xanthine derivatives situated in India.
It specialise in developing and manufacturing Highly Potent Active Pharmaceutical Ingredients (HPAPIs) critical for various therapeutic segments such as Anti-cancer, Anti-Asthma, Anti-Hypertensive etc. In 2001, the Company commissioned first API manufacturing Unit in Dombivali (Unit 1) and started Xanthine Unit; further it commissioned first API manufacturing Unit 4 in Tarapur for Regulated Markets in 2005; commissioned Caffeine production at Unit 5 with a capacity of 100 Metric Tonnes (MT) per month in 2016.

About Desh Rakshak Aushdhalaya Ltd

The flagship company Desh Rakshak Aushdhalaya Limited of Bhagwant Group was originally started in 1901 as a Proprietorship Concern by Late Shri Bhagwant Rai Jain, a well renowned Vaidya Father of Late Dr. Paras Kumar Jain.
The Concern was converted into a Private Limited Company in Jul.'94. Desh Rakshakare the oldest manufacturer of Pure Ayurvedic and Herbal Products as discovered by the Ancient Seers & Sages.
The medicines are categorized into Proprietary & Classical Medicines.
They are currently manufacturing around 450 products (Proprietary & Classical mix) and all of these medicines are manufactured as per the prescribed norms and standards of the Indian Government.
The Company was earlier operating the traditional process of manufacturing ayurvedic medicines. Up to 1976, the company producing ethical products of ayurvedic medicines which were supplied to ayurvedic dispensaries.

FAQs for the comparison of Aarti Pharmalabs Ltd and Desh Rakshak Aushdhalaya Ltd

Which company has a larger market capitalization, Aarti Pharmalabs Ltd or Desh Rakshak Aushdhalaya Ltd?

Market cap of Aarti Pharmalabs Ltd is 5,813 Cr while Market cap of Desh Rakshak Aushdhalaya Ltd is 19 Cr

What are the key factors driving the stock performance of Aarti Pharmalabs Ltd and Desh Rakshak Aushdhalaya Ltd?

The stock performance of Aarti Pharmalabs Ltd and Desh Rakshak Aushdhalaya Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aarti Pharmalabs Ltd and Desh Rakshak Aushdhalaya Ltd?

As of June 14, 2026, the Aarti Pharmalabs Ltd stock price is INR ₹641.25. On the other hand, Desh Rakshak Aushdhalaya Ltd stock price is INR ₹35.0.

How do dividend payouts of Aarti Pharmalabs Ltd and Desh Rakshak Aushdhalaya Ltd compare?

To compare the dividend payouts of Aarti Pharmalabs Ltd and Desh Rakshak Aushdhalaya Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.